Abstract
Purpose
Diphenidine is a potent synthetic dissociative anesthetic drug that has recently emerged in drug markets of Europe, Japan and America. The aim of this review is to summarize the current knowledge about this drug concerning its chemistry, synthesis, prevalence, pharmacology, toxicology and metabolism, as well as its legal status. Analytical methodologies developed for the determination of diphenidine in biological specimens and published diphenidine-related intoxications, fatal or not, are also presented.
Methods
All the reviewed information was gathered through a detailed search of PubMed and the World Wide Web using proper keywords.
Results
Diphenidine is not approved for medical or veterinary use, but it is used illicitly around the world for recreational purposes or as a substitute of other controlled dissociative drugs. It is available through the Internet in powder form for oral administration, smoking or vaporization. Since its first appearance in the drug market in 2013, seizures have been reported worldwide and its abuse has already caused intoxications and deaths in Europe and Japan, thus leading to its scheduling in the United Kingdom and Canada during the second semester of 2016.
Conclusions
Diphenidine is a harmful dissociative drug that recently gained serious concern for public health. International and local authorities should take all the appropriate actions and measures to avoid the expansion of this new threat.
Similar content being viewed by others
References
Zawilska JB (2015) “Legal highs”—an emerging epidemic of novel psychoactive substances. Int Rev Neurobiol 120:273–300
European Monitoring Center for Drugs and Drug Addiction (EMCDDA) (2017) EMCDDA–Europol 2016 annual report on the implementation of council decision 2005/387/JHA.http://www.emcdda.europa.eu/system/files/publications/4724/TDAN17001ENN_PDFWEB.pdf. Accessed 10 Feb 2018
Simonato P, Corazza O, Santonastaso P, Corkery J, Deluca P, Davey Z, Blaszko U, Schifano F (2013) Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey. Hum Psychopharmacol 28:324–331
Baumeister D, Tojo LM, Tracy DK (2015) Legal highs: staying on top of the flood of novel psychoactive substances. Ther Adv Psychopharmacol 5:97–132
Deluca P, Davey Z, Di Furia L, Farre M, Flesland LH, Mannonen H, Majava A, Peltoniemi T, Pasinetti P, Pezzolesi C, Scherbaum N, Siemann H, Skutle A, Torrens M, van der Kreeft P, Iversen E, Schifano F (2012) Identifying emerging trends in recreational drug use: outcomes from the Psychonaut Web Mapping Project. Prog Psychopharmacol Biol Psychiatry 39:221–226
Christian E (1924) Reaction of organo-magnesium compounds on α-amino nitriles. Bull Soc Chim Belg 33:483
Morris H, Wallach J (2014) From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Test Anal 6:614–632
Helander A, Beck O, Bäckberg M (2015) Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine. Clin Toxicol 53:446–553
Wink CS, Michely JA, Jacobsen-Bauer A, Zapp J, Maurer HH (2016) Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC–MS, LC–MSn, and LC-HR-MSn. Drug Test Anal 8:1005–1014
Tamminga CA, Tanimoto K, Kuo S, Chase TN, Contreras PC, Rice KC, Jackson AE, O’ Donohue TL (1987) PCP-induced alterations in cerebral glucose utilization in rat brain: blockade by metaphit, a PCP-receptor-acylating agent. Synapse 1:497–504
Domino EF, Miller SC (2009) The Pharmacology of dissociatives. In: Ries RK, Fiellin DA, Miller SC, Saitz R (eds) Addiction medicine. Lippincott Williams & Wilkins, A Wolters Kluwer Business, Philadelphia, pp 231–240
Hearne E, Van Hout MC (2016) “Trip-sitting” in the black hole: a netnographic study of dissociation and indigenous harm reduction. J Psychoactive Drugs 48:233–242
Palamar JJ, Salomone A, Gerace E, Di Corcia D, Vincenti M, Cleland CM (2017) Hair testing to assess both known and unknown use of drugs amongst ecstasy users in the electronic dance music scene. Int J Drug Policy 48:91–98
Wurita A, Hasegawa K, Minakata K, Watanabe K, Suzuki O (2014) A large amount of new designer drug diphenidine coexisting with a synthetic cannabinoid 5-fluoro-AB-PINACA found in a dubious herbal product. Forensic Toxicol 32:331–337
Hasegawa K, Wurita A, Minakata K, Gonmori K, Nozawa H, Yamagishi I, Watanabe K, Suzuki O (2015) Postmortem distribution of AB-CHMINACA, 5-fluoro-AMB, and diphenidine in body fluids and solid tissues in a fatal poisoning case: usefulness of adipose tissue for detection of the drugs in unchanged forms. Forensic Toxicol 33:45–53
Uchiyama N, Shimokawa Y, Kawamura M, Kikura-Hanajiri R, Hakamatsuka T (2014) Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in illegal products. Forensic Toxicol 32:266–281
Odoardi S, Romolo FS, Strano-Rossi S (2016) A snapshot on NPS in Italy: distribution of drugs in seized materials analysed in an Italian forensic laboratory in the period 2013–2015. Forensic Sci Int 265:116–120
Kudo K, Usumoto Y, Kikura-Hanajiri R, Sameshima N, Tsuji A, Ikeda N (2015) A fatal case of poisoning related to new cathinone designer drugs, 4-methoxy PV8, PV9, and 4-methoxy PV9, and a dissociative agent, diphenidine. Leg Med 17:421–426
Minakata K, Yamagishi I, Nozawa H, Hasegawa K, Wurita A, Gonmori K, Suzuki M, Watanabe K, Suzuki O (2015) Diphenidine and its metabolites in blood and urine analyzed by MALDI-Q-TOF mass spectrometry. Forensic Toxicol 33:402–408
Cayman Chemical (2014) Diphenidine (hydrochloride) safety data sheet. https://www.caymanchem.com/msdss/15518m.pdf. Accessed 23 Oct 2017
Drugs-forum (2013) Diphenidine (1,2-diphenylethylpiperidine) drug info. https://drugs-forum.com/threads/diphenidine-1-2-diphenylethylpiperidine-drug-info.210615/. Accessed 4 Nov 2017
Gerace E, Bovetto E, Di Corcia D, Vincenti M, Salomone A (2017) A case of nonfatal intoxication associated with the recreational use of diphenidine. J Forensic Sci 62:1107–1111
Kusano M, Zaitsu K, Taki K, Hisatsune K, Nakajima J, Moriyasu T, Asano T, Hayashi Y, Tsuchihashi H, Ishii A (2018) Fatal intoxication by 5F-ADB and diphenidine: detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q-TOFMS. Drug Test Anal 10:284–293
Legislation.gov.uk (2016) Psychoactive Substances Act 2016. http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted. Accessed 23 Oct 2017
Government of Canada (2016) Regulations amending the food and drug regulations (Parts G and J - lefetamine, AH-7921, MT-45 and W-18). http://www.gazette.gc.ca/rp-pr/p2/2016/2016-06-01/html/sor-dors106-eng.php. Accessed 23 Oct 2017
Elliott SP, Brandt SD, Wallach J, Morris H, Kavanagh PV (2015) First reported fatalities associated with the ‘research chemical’ 2-methoxydiphenidine. J Anal Toxicol 39:287–293
Pubchem Open Chemistry Database (2018) 1-(1,2-Diphenylethyl)piperidine. https://pubchem.ncbi.nlm.nih.gov/compound/206666. Accessed 25 Feb 2018
Wikipedia (2017) Diphenidine. https://en.wikipedia.org/wiki/Diphenidine. Accessed 23 Oct 2017
Psychonautwiki (2018) Diphenidine. https://psychonautwiki.org/wiki/Diphenidine. Accessed 23 Feb 2018
Wallach J, Kavanagh P, McLaughlin G, Morris N, Power J, Elliott S, Mercier M, Lodge D, Morris H, Dempster N, Brandt S (2015) Preparation and characterization of the ‘research chemical’ diphenidine, its pyrrolidine analogue, and their 2,2-diphenylethyl isomers. Drug Test Anal 7:358–367
Maddox VH (1981) The historical development of phencyclidine. In: Domino EF (ed) PCP (phencyclidine): historical and current perspectives. NPP Books, Ann Arbor, pp 1–8
Cheng BK, Gray NM (1989) Preparation of 1,2-diarylethylamines for treatment of neurotoxic injury. EU patent no. EP346791A1
Berger ML, Schweifer A, Rebernik P, Hammerschmidt F (2009) NMDA receptor affinities of 1,2-diphenylethylamine and 1-(1, 2-diphenylethyl) piperidine enantiomers and of related compounds. Bioorg Med Chem 17:3456–3462
Geyer PM, Hulme MC, Irving JP, Thompson PD, Ashton RN, Lee RJ, Johnson L, Marron J, Banks CE, Sutcliffe OB (2016) Guilty by dissociation-development of gas chromatography-mass spectrometry (GC-MS) and other rapid screening methods for the analysis of 13 diphenidine-derived new psychoactive substances (NPSs). Anal Bioanal Chem 408:8467–8481
Wille SMR, Richeval C, Nachon-Phanithavong M, Gaulier JM, Di Fazio V, Humbert L, Samyn N, Allorge D (2018) Prevalence of new psychoactive substances and prescription drugs in the Belgian driving under the influence of drugs population. Drug Test Anal 10:539–547
Kinoshita H, Tanaka N, Takakura A, Abe H, Kumihashi M, Shibayama T, Jamal M, Ito A, Tsutsui K, Kimura S, Iwase H, Ameno K (2017) An autopsy case of death by combined use of benzodiazepines and diphenidine. Soud Lek 62:40–43 (PMID: 29227117)
Rogawski M (1993) Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol Sci 14:325–331
Espinosa L, Itzstein C, Cheynel H, Delmas PD, Chenu C (1999) Active NMDA glutamate receptors are expressed by mammalian osteoclasts. J Physiol 518:47–53
Wallach J, Kang H, Colestock T, Morris H, Bortolotto ZA, Collingridge GL, Lodge D, Halberstadt AL, Brandt SD, Adejare A (2016) Pharmacological investigations of the dissociative ‘legal highs’ diphenidine, methoxphenidine and analogues. PLoS One 11:e0157021. https://doi.org/10.1371/journal.pone.0157021
Luethi D, Hoener MC, Liechti ME (2018) Effects of the new psychoactive substances diclofensine, diphenidine, and methoxphenidine on monoaminergic systems. Eur J Pharmacol 819:242–247
Kasé Y, Yuizono T, Muto M (1961) Piperidino groups in antitussive activity. J Med Chem 6:118–122
Cahusac PMB, Senok SS, Hitchcock IS, Genever PG, Baumann KI (2005) Are unconventional NMDA receptors involved in slowly adapting type I mechanoreceptor responses? Neuroscience 133:763–773
Salomone A, Gazzilli G, Di Corcia D, Gerace E, Vincenti M (2016) Determination of cathinones and other stimulant, psychedelic, and dissociative designer drugs in real hair samples. Anal Bioanal Chem 408:2035–2042
Strano Rossi S, Odoardi S, Gregori A, Peluso G, Ripani L, Ortar G, Serpelloni G, Romolo FS (2014) An analytical approach to the forensic identification of different classes of new psychoactive substances (NPSs) in seized materials. Rapid Commun Mass Spectrom 28:1904–1916
National Institute of Health Sciences (Tokyo) (2017) Data search system for new psychoactive substances. http://npsdb.nihs.go.jp/Search/. Accessed 23 Oct 2017
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There are no financial or other relations that could lead to a conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Katselou, M., Papoutsis, I., Nikolaou, P. et al. Diphenidine: a dissociative NPS makes an entrance on the drug scene. Forensic Toxicol 36, 233–242 (2018). https://doi.org/10.1007/s11419-018-0421-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11419-018-0421-1